{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:33Z","timestamp":1776329853241,"version":"3.50.1"},"reference-count":13,"publisher":"Baskent University","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.6002\/ect.2025.0228","type":"journal-issue","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:29:30Z","timestamp":1765780170000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"23","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093-2109. doi:10.1111\/j.1600-6143.2011.03686.x","DOI":"10.1111\/j.1600-6143.2011.03686.x"},{"key":"ref1","unstructured":"2. S\u00f6zen H, Kozan R, H\u00fcseyn B, Fidan K, Dalgi\u00e7 A. Renal transplantation in pediatric patients: surgical outcomes of 15 years of single-center experience. Exp Clin Transplant. 2025;23(7):460-465. doi:0.6002\/ect.2025.0066"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Seyahi N, Kocyigit \u0130, Eren N, et al. Current status of kidney replacement therapy in T\u00fcrkiye: a summary of 2023 Turkish Society of Nephrology Registry Report. Turk J Nephrol. 2025;34(2):141-148. doi:10.5152\/turkjnephrol.2025.24978","DOI":"10.5152\/turkjnephrol.2025.24978"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Ong SC, Gaston RS. Thirty years of tacrolimus in clinical practice. Transplantation. 2021;105(3):484-495. doi:10.1097\/TP.0000000000003350","DOI":"10.1097\/TP.0000000000003350"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Shrestha BM. Two decades of tacrolimus in renal transplant: basic science and clinical evidences. Exp Clin Transplant. 2017;15(1):1-9. doi:10.6002\/ect.2016.0157","DOI":"10.6002\/ect.2016.0157"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Vincenti F. Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. Transplant Proc. 2001;33(1-2):1019-2100. doi:10.1016\/s0041-1345(00)02312-5","DOI":"10.1016\/S0041-1345(00)02312-5"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation. 1997;64(3):436-443. doi:10.1097\/00007890-199708150-00012","DOI":"10.1097\/00007890-199708150-00012"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Jensik SC. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. Transplant Proc. 1998;30(4):1216-1218. doi:10.1016\/s0041-1345(98)00216-4","DOI":"10.1016\/S0041-1345(98)00216-4"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Higgins JP, Carlisle JW, Moniri NH, Gupta S, Oduah EI, Leal T. Sotorasib for the treatment of locally advanced\/metastatic non-small cell lung cancer. Future Oncol. 2025;21(1):63-71. doi:10.1080\/14796694.2024.2430172","DOI":"10.1080\/14796694.2024.2430172"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Lee A. Sotorasib: a review in KRAS G12C mutation-positive non-small cell lung cancer. Target Oncol. 2022;17(6):727-733. doi:10.1007\/s11523-022-00922-w. Published correction appears in Target Oncol. 2023;18(1):177.","DOI":"10.1007\/s11523-022-00922-w"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Liaigre L, Perrier Q, Orhon P, et al. Sotorasib associated with tacrolimus and everolimus: a significant drug interaction in lung transplant patients. Transpl Immunol. 2022;74:101678. doi:10.1016\/j.trim.2022.101678","DOI":"10.1016\/j.trim.2022.101678"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41(4):674-680. doi:10.1345\/aph.1H423","DOI":"10.1345\/aph.1H423"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Barbari A, Maawad M, Kfoury Kassouf H, Kamel G. Mammalian target of rapamycin inhibitors and nephrotoxicity: fact or fiction. Exp Clin Transplant. 2015;13(5):377-386. doi:10.6002\/ect.2015.0193","DOI":"10.6002\/ect.2015.0193"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:52:53Z","timestamp":1765781573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2025\/23\/11\/0\/748\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2025.0228","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}